Scholars Central

Conference abstractPublished 17 Jun 2026

Advances in Clinical Management of Age-Related Macular Degeneration: From Precision Diagnosis to Novel Therapeutics

Authors: Emily Y. Chew

Division of Epidemiology and Clinical Applications, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Age-related macular degeneration (AMD) remains one of the leading causes of irreversible vision loss among older adults worldwide. Recent advances in retinal imaging, biomarker discovery, and targeted pharmacological therapies have significantly improved disease detection and treatment outcomes. This presentation reviews the latest developments in anti-VEGF therapy, complement inhibitors, sustained drug-delivery systems, and emerging gene therapies designed to preserve retinal function. The session also discusses advances in optical coherence tomography, artificial intelligence-assisted retinal screening, and individualized treatment protocols that enable clinicians to optimize patient care while reducing treatment burden. Future research directions include regenerative medicine, stem cell therapies, and precision ophthalmology aimed at preventing vision loss and improving long-term visual outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Experimental Ophthalmology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Experimental Ophthalmology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Emily Y. Chew”